Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Esposito I, de Leone A, Di Gregorio G, Giaquinto S, de Magistris L, Ferrieri A, Riegler G.

World J Gastroenterol. 2007 Dec 7;13(45):6016-21.

2.
3.

[Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].

Liu ZJ, Wei H, Duan LP, Zhu SW, Zhang L, Wang K.

Zhonghua Yi Xue Za Zhi. 2016 Jun 28;96(24):1896-902. doi: 10.3760/cma.j.issn.0376-2491.2016.24.005. Chinese.

PMID:
27373356
4.

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A.

World J Gastroenterol. 2009 Jun 7;15(21):2628-31.

5.

Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Rana SV, Sharma S, Kaur J, Sinha SK, Singh K.

Digestion. 2012;85(3):243-7. doi: 10.1159/000336174.

PMID:
22472730
6.

Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.

Ning Y, Lou C, Huang Z, Chen D, Huang H, Chen L, Zhang B, Dai N, Zhao J, Zhen X.

Hell J Nucl Med. 2016 May-Aug;19(2):124-9. doi: 10.1967/s002449910365.

7.

Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.

Ghoshal UC, Srivastava D, Ghoshal U, Misra A.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122.

PMID:
24849768
9.

Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?

Stoicescu A, Andrei M, Becheanu G, Stoicescu M, Nicolaie T, Diculescu M.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):766-72.

PMID:
23272525
10.

Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.

Kasir R, Zakko S, Zakko P, Adler M, Lee A, Dhingra S, Guttermuth C.

Dig Dis Sci. 2016 Mar;61(3):846-51. doi: 10.1007/s10620-015-3872-9.

PMID:
26362282
11.
12.

[Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].

Łokieć K, Klupińska G, Walecka-Kapica E, Błońska A.

Pol Merkur Lekarski. 2014 May;36(215):307-10. Polish.

PMID:
24964506
13.

Small intestine bacterial overgrowth in patients with irritable bowel syndrome.

Carrara M, Desideri S, Azzurro M, Bulighin GM, Di Piramo D, Lomonaco L, Adamo S.

Eur Rev Med Pharmacol Sci. 2008 May-Jun;12(3):197-202.

PMID:
18700692
14.

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A.

Aliment Pharmacol Ther. 2005 Jun 1;21(11):1391-5.

15.

Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan.

Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W.

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):371-5. doi: 10.4103/1319-3767.87176.

16.

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome.

Boltin D, Perets TT, Shporn E, Aizic S, Levy S, Niv Y, Dickman R.

Ann Clin Microbiol Antimicrob. 2014 Oct 17;13:49. doi: 10.1186/s12941-014-0049-x.

17.

Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.

Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2013 May;17(10):1314-20.

18.

[Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome].

Park JS, Yu JH, Lim HC, Kim JH, Yoon YH, Park HJ, Lee SI.

Korean J Gastroenterol. 2010 Oct;56(4):242-8. Korean.

19.

Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.

Scarpellini E, Giorgio V, Gabrielli M, Lauritano EC, Pantanella A, Fundarò C, Gasbarrini A.

J Pediatr. 2009 Sep;155(3):416-20. doi: 10.1016/j.jpeds.2009.03.033.

PMID:
19535093
20.

Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS.

Banik GD, De A, Som S, Jana S, Daschakraborty SB, Chaudhuri S, Pradhan M.

J Breath Res. 2016 May 10;10(2):026010. doi: 10.1088/1752-7155/10/2/026010.

PMID:
27163246

Supplemental Content

Support Center